Sinopharm Group Co., Ltd. (X2S)
FSX
Real-time Data
06:00 AM
Day's Range
1.8052 wk Range
1.69Overview - X2S - Sinopharm Group Co., Ltd.
Key Statistics
Valuation
Enterprise Value
12.19B
P/E (Trailing)
‪6.20‬
Price / Sales (TTM)
‪0.0097‬
Price / Book
‪0.50‬
EV / EBITDA
‪5.01‬
Profitability
Profit Margin
‪1.23%‬
Operating Margin
‪2.18%‬
Return on Assets
‪2.62%‬
Return on Equity
‪8.10%‬
Ownership
Shares Outstanding
3.12B
Float
1.27B
Held by Insiders
‪0.00%‬
Held by Institutions
‪75.92%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪1.86‬
200-Day Avg
‪2.09‬
Dividends
Payout Ratio
‪29.49%‬
Frequency
Annual
Market Cap - X2S - Sinopharm Group Co., Ltd.
Peers - X2S - Sinopharm Group Co., Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on FSX.
- X2SFSXSinopharm Group Co., Ltd.5.61BMarket Cap-18.94%52-week change6.21P/E (Trailing)‪1.23%‬Profit Margin
- ABGFSXCencora, Inc.3.58TMarket Cap+38.36%52-week change17.14P/E (Trailing)‪54.77%‬Profit Margin
- MCKFSXMcKesson Corporation83.01BMarket Cap+17.53%52-week change22.32P/E (Trailing)‪1.11%‬Profit Margin
- CLHFSXCardinal Health Inc.45.29BMarket Cap+35.30%52-week change31.41P/E (Trailing)‪0.67%‬Profit Margin
- S5YAFSXSigma Healthcare Limited19.85BMarket Cap+9.30%52-week change57.33P/E (Trailing)‪6.28%‬Profit Margin
- HS2FSXHenry Schein, Inc.8.35BMarket Cap+21.09%52-week change25.68P/E (Trailing)‪2.96%‬Profit Margin
- S1RFSXShanghai Pharmaceuticals Holding Co. Ltd.4.52BMarket Cap-11.47%52-week change6.05P/E (Trailing)‪2.01%‬Profit Margin
Profile Summary - X2S - Sinopharm Group Co., Ltd.
About
Sinopharm Group Co., Ltd. is a prominent healthcare conglomerate that plays a vital role in China's pharmaceutical industry. Specializing in the manufacturing, distribution, and retail of healthcare products, this state-owned enterprise is integral to ensuring China's healthcare supply chain remains robust and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
